Diverse and inclusive representation in clinical trials matters. A healthier, more equitable future requires a continuous commitment to intentional change. Read more about this important initiative below. #WeAreLilly
Outdated restrictions from the 1990s have prevented HIV-positive individuals and those on PrEP from participating in clinical studies, including those for life-saving cancer treatments. In celebration of Pride Month, SGM Alliance is proud to announce that several companies are standing in solidarity with LGBTQIA+ communities to proactively address disparities and drive positive historical change. You can read the open letter endorsed by those companies here. To read the full press release, visit our website www.SGMAlliance.org #LGBTPride #StopTheCopyPaste #SGM #SexualandGenderMinorities
Absolutely crucial initiative! Diverse representation in clinical trials is key to advancing health equity and improving outcomes. Proud to see this commitment from #WeAreLilly
gostei
Bravo to Eli Lilly for its commitment to diversity and inclusion in clinical trials! 🌍 This initiative is essential to ensure fair and robust research results. Studies show that diversity in clinical trials improves the quality of results and ensures beneficial treatments for all populations (Corneli et al., 2023). Thank you for leading the way to a healthier, more inclusive future! #WeAreLilly